tiprankstipranks
Advertisement
Advertisement

MBRX Stock Latest News

Moleculin Biotech (MBRX) Q2 Earnings Cheat Sheet
Pre-EarningsMoleculin Biotech (MBRX) Q2 Earnings Cheat Sheet
9d ago
MBRX
Moleculin: Buy Rating Maintained as MIRACLE Trial Progress Offsets Dilution; McCarthy Trims Price Target After Equity Financing
PremiumRatings
Moleculin: Buy Rating Maintained as MIRACLE Trial Progress Offsets Dilution; McCarthy Trims Price Target After Equity Financing
10d ago
MBRX
Moleculin Biotech completes $9.3M equity financing
PremiumCompany Announcements
Moleculin Biotech completes $9.3M equity financing
22d ago
8K
MBRX
Moleculin Biotech updates preliminary blinded results from MIRACLE trial Part A
PremiumThe Fly
Moleculin Biotech updates preliminary blinded results from MIRACLE trial Part A
26d ago
MBRX
Moleculin Biotech Highlights Promising MIRACLE Trial Remission Data
PremiumCompany Announcements
Moleculin Biotech Highlights Promising MIRACLE Trial Remission Data
26d ago
8K
MBRX
Moleculin Biotech files to sell 4.57M shares of common stock, warrants
PremiumThe FlyMoleculin Biotech files to sell 4.57M shares of common stock, warrants
28d ago
MBRX
Moleculin Biotech announces unblinded efficacy results from MIRACLE trial Part A
Premium
The Fly
Moleculin Biotech announces unblinded efficacy results from MIRACLE trial Part A
2M ago
MBRX
Moleculin Biotech Updates Investors With New Presentation
Premium
Company Announcements
Moleculin Biotech Updates Investors With New Presentation
2M ago
8K
MBRX
Moleculin Biotech Reports Promising Annamycin AML Trial Data
PremiumCompany Announcements
Moleculin Biotech Reports Promising Annamycin AML Trial Data
2M ago
8K
MBRX
Moleculin Highlights Strong Market Interest in Annamycin AML Therapy
PremiumCompany Announcements
Moleculin Highlights Strong Market Interest in Annamycin AML Therapy
3M ago
8K
MBRX
Moleculin Highlights Annamycin Cardiac Safety Data at ASCO
PremiumCompany Announcements
Moleculin Highlights Annamycin Cardiac Safety Data at ASCO
3M ago
8K
MBRX
Moleculin Biotech Releases Updated Investor Information Presentation
PremiumCompany Announcements
Moleculin Biotech Releases Updated Investor Information Presentation
3M ago
8K
MBRX
Moleculin Highlights Annamycin Cardiac Safety Data at ASCO
PremiumCompany AnnouncementsMoleculin Highlights Annamycin Cardiac Safety Data at ASCO
3M ago
8K
MBRX
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress and Safety Profile Support Unchanged $22 Price Target
Premium
Ratings
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress and Safety Profile Support Unchanged $22 Price Target
3M ago
MBRX
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target
Premium
Ratings
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target
3M ago
MBRX
Moleculin Biotech expects first unblinding of MIRACLE trial data by June 30
PremiumThe Fly
Moleculin Biotech expects first unblinding of MIRACLE trial data by June 30
3M ago
MBRX
Moleculin Nears First Unblinding in Pivotal MIRACLE Trial
PremiumCompany Announcements
Moleculin Nears First Unblinding in Pivotal MIRACLE Trial
3M ago
8K
MBRX
Moleculin announces publication on cardiac safety profiloe of annamycin
PremiumThe Fly
Moleculin announces publication on cardiac safety profiloe of annamycin
4M ago
MBRX
Moleculin highlights favorable cardiac safety data for Annamycin
PremiumCompany Announcements
Moleculin highlights favorable cardiac safety data for Annamycin
4M ago
8K
MBRX
Moleculin Biotech issued liposomal Annamycin patent in Hong Kong
PremiumThe FlyMoleculin Biotech issued liposomal Annamycin patent in Hong Kong
4M ago
MBRX
Moleculin Secures New Hong Kong Patent for Annamycin
Premium
Company Announcements
Moleculin Secures New Hong Kong Patent for Annamycin
4M ago
8K
MBRX
Moleculin Highlights Promising Preclinical Data for L-ANN
Premium
Company Announcements
Moleculin Highlights Promising Preclinical Data for L-ANN
4M ago
8K
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >